About Us2020-03-25T09:51:32-05:00


LifeScienceRisk specializes in core liability consisting of Product Liability, Errors and Omissions Liability and General Liability for Life Science companies engaged in the discovery, development, manufacturing, distribution and promotion of products including pharmaceuticals, medical devices, biotechnology, dietary supplements as well as compounds and devices in human clinical trials. We offer a comprehensive suite of coverages which are distributed by specialist retail and wholesale brokers who value a facility that both understands their clients’ needs and strives to provide meaningful and stable financial protection. We offer expertise to firms from innovative start-up ventures to large sophisticated companies with worldwide operations. Leading the LifeScienceRisk operation is Mark D. Wood, a prominent figure in the Life Science insurance community, with over 35 years of experience in specialty commercial insurance, loss control and underwriting in the Healthcare and Life Science segments.


LifeScienceRisk is committed to providing outstanding specialty insurance solutions and quality services to protect and partner with Life Science industry companies as they research, innovate and develop products, treatments and cures to improve the human condition around the globe.

Brand Pharmaceuticals
Firms that innovate and manufacture prescription drugs with the authorization of the FDA under the New Drug Application (NDA) process.
Generic Pharmaceuticals
Firms that produce bioequivalent replications of brand-name drugs in terms of dosage, safety, strength, route of administration, quality, performance and intended use with the authorization of the FDA under the Abbreviated New Drug Application (ANDA) process.
Substances used in the manufacturing of final drug products that provide a direct therapeutic effect in the management, treatment or prevention of disease.
The combining of drugs for specific patients with needs that can’t be met by commercially available medicines.
Appliances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or other conditions with the authorization of the FDA under the Investigational Device Exemption (IDE) or premarket notification (510k) process. Medical devices range from non-invasive to implantable products.
The process by which new candidate medications are discovered and studied prior to human testing.
Medicinal preparations made from living organisms that govern the rhythmic occurrence of certain biochemical, physiologic, and behavioral phenomena of the human genome with the authorization of the FDA under the Biologics License Application (BLA).
Substances prepared from the causative agent of a disease or a synthetic substitute that are used to stimulate the production of antibodies and provide immunity against one or several diseases with the authorization of the FDA under the BLA.
Includes vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. The FDA regulates the dietary supplement industry under the 1994 Dietary Supplement Health and Education Act and the New Dietary Ingredient (NDI) notification process. Dietary Supplements are also impacted by California Proposition 65 (The Safe Drinking Water and Toxic Enforcement Act, which enforces Dietary and Herbal companies to provide “clear and reasonable warning” on their labels). LSR offers standalone coverage for Proposition 65 exposure as well as sublimit coverage within our product liability policy.
Research studies with human volunteer participants to evaluate one or more health-related interventions to determine efficacy of a novel compound or device. Human Clinical Trials are overseen by the FDA Center for Drug Evaluation and Research through the review and approval of the study protocols and informed consent documents.

Screenshot 2016-08-09 15.03.01

President & CEO

Mark Wood is President and CEO of LifeScienceRisk. LifeScienceRisk offers appointed brokers a single source for both primary and excess insurance for Life Science firms in the pharmaceutical, medical device and nutritional supplement sectors.

Mark has over 35 years of experience in specialty commercial insurance loss control and underwriting, with an emphasis on the Healthcare and Life Science industries specializing in heavy casualty underwriting including Medical Professional, Medical Product and E&O Liability.

His career includes positions of increasing responsibility at a number of U.S. insurance companies, where he was responsible for Medical Product Liability, related Professional Liability and multi-line Property and Casualty underwriting operations focused on the Life Science industry.

Mark holds an AAS Professional Nursing degree from SUNY Health Sciences, a BA Health Care Administration from Minnesota’s Metropolitan State University, an Associate in Risk Management (ARM) Designation and the Chartered Property Casualty Underwriter (CPCU) Designation. Additionally, he attended the Wharton School’s Insurance Executive Development Program.


Chief Underwriting Officer

Catherine Gill joined LifeScienceRisk in October 2012 and is responsible for management of key producer relationships and underwriting a profitable book of Life Science Product Liability business for the facility. She also is the deputy underwriter for the facility and assists in the development of products, guidelines and management of our relationships with our underwriting partners. Catherine places an emphasis on customer service, establishing relationships with insurance brokers and securing new business placements.

Prior to joining LifeScienceRisk, Catherine was with CNA Insurance Company for seven years as a dedicated Life Science underwriter. During her tenure, she worked her way through the ranks from Underwriting Trainee in 2005 to her role as Underwriting Consultant when she left in 2012. Catherine has worked with a broad cross section of the industry from start-ups to Fortune 500 firms, including pharmaceutical, biopharmaceutical, device and nutritional supplement companies.

Catherine graduated from New York University in 2005 with a BA in Medical Ethics.



Roohi Khan joined Ryan Specialty Group in July 2011 working with the Long Term Care Team of Sapphire Blue. She transitioned to LifeScienceRisk in 2014 with an initial focus on nutritional supplement business. Her role has expanded and she responsible for underwriting a profitable and diversified book of business encompassing pharmaceutical, medical device and nutritional supplement firms. With her background as a physician, Roohi provides extensive and invaluable knowledge and a remarkable underwriting perspective to the team.

Roohi is a 15 year veteran in the insurance industry. She has enjoyed various underwriting positions with upward mobility and greater responsibilities. Roohi devoted seven years with CNA Insurance Company as an underwriter specializing in Allied Health Care, Long Term Care, Hospital and Miscellaneous Health Care business. In addition, during that time, Roohi gained experience in Alternative Risk Transfer. Prior to joining Ryan Specialty Group, Roohi spent four years with Beazley Group, as a dedicated Long Term Care underwriter.

Roohi earned her M.D. – Doctor of Medicine from Uniremhos Medical School, Santo Domingo, DR.


Senior Underwriter

Vivian joined LifeScienceRisk in July 2012, and is responsible for management of key producer relationships and underwriting a profitable book of Life Science Product Liability business for the facility.

Throughout her 24 years in the business, Vivian has enjoyed a diverse career spanning various underwriting positions in specialty Professional Liability, and Medical Product Liability. Prior to joining LifeScienceRisk, Vivian spent 10 years with CNA Insurance Company as an underwriter specializing in meeting the liability insurance needs of Life Science companies. Vivian has worked with a broad cross section of the Life Science industry, but has had a specialized focus on firms producing generic pharmaceuticals and drug delivery technologies.

Vivian graduated from DePaul University with a BS in Business Administration and holds a CLCS certification.

Eric Rush

Senior Underwriter

Eric Rush is a Senior Underwriter at LifeScienceRisk. He brings over 25 years of experience in the Commercial P&C Insurance Industry. Since May of 2006, Eric’s area of expertise has been focused on the Life Science and Technology industries.

Over the span of Eric’s career, he has worked across a vast array of product lines, including Property and Casualty, Workers’ Compensation, Products Liability, Clinical Trials and Professional Liability, as well as international coverages. Prior to joining LifeScienceRisk, Eric developed Property and Casualty capabilities within the Life Science vertical at Navigators Management Company with responsibilities across the entire country. Before joining Navigators Management Company, Eric was an Underwriting Consultant at OneBeacon Technology Insurance. Eric started his insurance career at FHP /Great States Insurance Company, where he began as an assistant underwriter and then was quickly promoted to Underwriter.

Eric holds a Bachelor of Science in Actuarial Science from Ball State University, Muncie, IN, where he also minored in Foundations of Business.


LifeScienceRisk is a Ryan Specialty Group (RSG) company. RSG is an international specialty insurance organization that provides underwriting management, wholesale brokerage and other specialty insurance services to brokers, agents and insurance carriers.

RSG was founded in 2010 by Patrick G. Ryan, the highly respected insurance veteran, founder and former Chairman and CEO of Aon Corporation. Mr. Ryan saw a need in the marketplace for a specialty organization dedicated exclusively to creating sophisticated insurance solutions for risks that demand innovation, proven leadership, outstanding industry expertise and quality services on behalf of brokers, agents and carriers.

The underwriting division of the company, RSG Underwriting Managers (RSGUM), delivers an independent and entrepreneurial approach to the specialty lines space by providing a unique platform for operational, legal, actuarial and technical support. RSGUM’s exceptional resources and back-office partnership allows underwriters to be focused on the risk itself, delivering a superior level of service to brokers, agents and carriers.

For more information, visit www.rsgum.com.

Life Science Risk is a series of RSG Underwriting Managers, LLC. RSG Underwriting Managers is a Delaware series limited liability company and a subsidiary of Ryan Specialty Group, LLC, specializing in underwriting management and other services for insurance products distributed through agents and brokers. In California: RSG Insurance Services, LLC License # 0E50879 ©2021 Ryan Specialty Group, LLC